文献速递妇科

卵巢癌初始治疗的医疗费用分析

Cost of Care for the Initial Management of Ovarian Cancer.
PubMed 文献 · Obstet Gynecol · 2017-01-01

本研究利用美国商业保险数据库,对2009至2012年确诊并接受手术和辅助化疗的卵巢癌患者进行回顾性队列分析,估算术后12个月内的医疗支出及自付费用。结果显示,每位患者的中位总医疗支出为93,632美元,自付费用中位数为2,988美元,约占总费用的3%。

要点

  • 卵巢癌患者术后第一年的中位总医疗支出为93,632美元。
  • 住院服务支出占37.8%,门诊服务占58.3%,门诊药物占3.8%。
  • 患者自付费用中位数为2,988美元,约占总费用的3%。

核心结论

  • 卵巢癌患者术后第一年的平均医疗费用约为100,000美元。
  • 患者以自付费用形式承担其中约3%的费用。

研究设计与样本

  • 回顾性队列研究,使用Truven Health MarketScan数据库,纳入2009至2012年确诊并接受手术和辅助化疗的卵巢癌女性。
  • 最终队列包含5,031名女性。

主要发现

  • 每位患者术后第一年的中位总医疗支出为93,632美元(四分位距62,319-140,140美元)。
  • 住院服务支出中位数为30,708美元(四分位距20,102-51,107美元;占37.8%)。
  • 门诊服务支出中位数为52,700美元(四分位距31,210-83,206美元;占58.3%)。
  • 门诊药物支出中位数为1,814美元(四分位距603-4,402美元;占3.8%)。
  • 患者自付费用中位数为2,988美元(四分位距1,649-5,088美元),其中门诊服务1,509美元(四分位距705-2,878美元),住院服务589美元(四分位距3-1,715美元),门诊药物351美元(四分位距149-656美元)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the cost of care during the first year after a diagnosis of ovarian cancer, estimate the sources of cost, and explore the out-of-pocket costs. METHODS: We performed a retrospective cohort study of women with ovarian cancer diagnosed from 2009 to 2012 who underwent both surgery and adjuvant chemotherapy using the Truven Health MarketScan database. This database is comprised of patients covered by commercial insurance sponsored by more than 100 employers in the United States. Medical expenditures, including physician reimbursement, for a 12-month period beginning on the date of surgery were estimated. All payments were examined, including out-of-pocket costs for patients. Payments were divided into expenditures for inpatient care, outpatient care (including chemotherapy), and outpatient drug costs. The 12-month treatment period was divided into three phases: surgery to 30 days (operative period), 1-6 months (adjuvant therapy), and 6-12 months after surgery. The primary outcome was the overall cost of care within the first year of diagnosis of ovarian cancer; secondary outcomes included assessment of factors associated with cost. RESULTS: A total of 26,548 women with ovarian cancer who underwent surgery were identified. After exclusion of patients with incomplete insurance enrollment or coverage, those who did not undergo chemotherapy, and those with capitated plans, our cohort consisted of 5,031 women. The median total medical expenditures per patient during the first year after the index procedure were $93,632 (interquartile range $62,319-140,140). Inpatient services accounted for $30,708 (interquartile range $20,102-51,107; 37.8%) in expenditures, outpatient services $52,700 (interquartile range $31,210-83,206; 58.3%), and outpatient drug costs $1,814 (interquartile range $603-4,402; 3.8%). The median out-of-pocket expense was $2,988 (interquartile range $1,649-5,088). This included $1,509 (interquartile range $705-2,878) for outpatient services, $589 (interquartile range $3-1,715) for inpatient services, and $351 (interquartile range $149-656) for outpatient drug costs. CONCLUSION: The average cost of care for women with ovarian cancer in the first year after surgery is approximately $100,000. Patients bear approximately 3% of these costs in the form of out-of-pocket expenses.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Bercow AS, Chen L, Chatterjee S, et al. Cost of Care for the Initial Management of Ovarian Cancer. Obstet Gynecol. 2017. PMID: 29112648. doi:10.1097/AOG.0000000000002317

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。